Novo Nordisk to phase out human insulin pens: report
Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.
Indiatimes14h
Bajaj Holdings & Investment Share Price
Bajaj Holdings & Investment Ltd. key Products/Revenue Segments include Dividend, Income From Sale Of Share & Securities, Interest and Rental Income for the year ending 31-Mar-2024.For the quarter ...